Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

10 results
Display

COVID-19 vaccines development in Africa: a review of current situation and existing challenges of vaccine production

Adeyemi O

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Unmasking the COVID-19 vaccination myths: intervention through collaboration

Cordero Jr. DA

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Quick drop of platelet counts in children with chronic immune thrombocytopenia after COVID-19 mRNA vaccination: case reports

Lassandro G, Carriero F, Palladino V, Vecchio GCD, Giordano P

Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by isolated thrombocytopenia. Many viruses and some vaccines have been identified as triggering the autoimmune process, including parvovirus, human immunodeficiency virus, Epstein-Barr...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Livedo reticularis following administration of ChAdOx1 nCoV-19 vaccine (AZD1222): a report of two cases

Kim JH, Uh JA, Kim HS, Lee SK, Kim MS, Lee UH

The cutaneous appearance of transient or persistent livedo reticularis is characterized by violaceous, mottled, ring-shaped interconnecting lesions that form a reticular or net-like pattern. It can occur physiologically in response...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Development of mucosal vaccine delivery: an overview on the mucosal vaccines and their adjuvants

Anggraeni R, Ana ID, Wihadmadyatami H

Currently, mucosal infectious diseases are still a very high global health burden, but there are few effective vaccines to prevent mucosal-borne diseases. The development of mucosal vaccines requires the selection...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Factors associated with intention to take COVID-19 vaccine among the university students in Bangladesh

Shuvo NA, Mondal MSH

Purpose: This study examined the Bangladeshi university students’ intention to take coronavirus disease 2019 (COVID-19) vaccines by assessing the Health Belief Model and Theory of Planned Behavior. Materials and Methods: University...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recombinant proteins of spike protein of SARS-CoV-2 with the Omicron receptor-binding domain induce production of highly Omicron-specific neutralizing antibodies

Kang H, Kim D, Min K, Park M, Kim SH, Sohn EJ, Choi BH, Hwang I

Various vaccines have been developed to fight severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the coronavirus disease 2019 pandemic. However, new variants of SARS-CoV-2 undermine the effort...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Field evaluation of the safety and immunogenicity of a classical swine fever virus E2 subunit vaccine in breeding and nursery animals on Jeju Island, South Korea

Jang G, Kim EJ, Cho SC, Moon SU, Kim BS, Kim J, Jeong KJ, Song K, Mun SH, Kang WM, Lee J, Park C, Yang HS, Lee C

Purpose: Classical swine fever (CSF) reemerged on CSF-free Jeju Island where vaccination is not practiced by the unintentional injection of a live attenuated vaccine (modified live attenuated vaccines–low-virulence Miyagi [MLV-LOM])...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Deep vein thrombosis and acute hepatitis after ChAdOx1 nCov-19 vaccination in a Charcot-MarieTooth patient: a case report

Napoli R, Visonà E

Monitoring of side effects after coronavirus disease 2019 (COVID-19) vaccination has become an important issue for health systems worldwide to ensure its safety. Recently cases of deep vein thrombosis (DVT),...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Identifying immunodominant multi-epitopes from the envelope glycoprotein of the Lassa mammarenavirus as vaccine candidate for Lassa fever

Rowaiye AB, Nwonu EJ, Asala TM, Ogu AC, Bur D, Chukwu C, Oli AN, Agbalalah T

Purpose: Lassa fever is a zoonotic acute viral hemorrhagic disease caused by Lassa virus (LASV). There is currently no licensed vaccine for the prevention of the disease. This study is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr